In addition, blocking NF-κB and sEH as well as enabling PPARα and PPARγ expression could alleviate neurodegenerative diseases such as Alzheimer’s disease (Certo et al., 2015, Prashantha et al., 2020). This evidence concerns the gene NFKB1 and Alzheimer disease.